Related Experiment Video
Updated: Aug 26, 2026

Establishment of a Novel Ex Vivo Lung Perfusion System for Rat Lungs After Circulatory Death
Published on: October 18, 2024
Lung perfusion with protective solution relieves lung injury in corrections of Tetralogy of Fallot
Bo Wei1, Yinglong Liu, Qiang Wang
1Department of Surgery, FuWai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. wi1bo1208@hotmail.com
Insights
Pulmonary perfusion with hypothermic solution improved lung function and reduced injury markers in children undergoing Tetralogy of Fallot repair. This method offers a protective effect against lung damage during cardiopulmonary bypass.
Area of Science:
- Cardiology
- Pediatric Surgery
- Pulmonology
Background:
- Tetralogy of Fallot repair often involves cardiopulmonary bypass (CPB), which can lead to lung injury.
- Lung injury post-CPB can manifest as impaired oxygenation and prolonged ventilation.
- Evaluating protective strategies for lung function during CPB is crucial in pediatric cardiac surgery.
Purpose of the Study:
- To assess the protective impact of pulmonary perfusion with a hypothermic solution on lung function following CPB in Tetralogy of Fallot correction.
- To investigate the underlying mechanisms of CPB-induced lung injury and the potential mitigation by the protective solution.
Main Methods:
- A randomized controlled trial involving 64 children with Tetralogy of Fallot undergoing CPB.
- The protective group received pulmonary perfusion with hypothermic solution, while the control group did not.
- Monitoring of hemodynamic and lung function parameters, measurement of inflammatory markers (TNF-α, IL-6, IL-8), endothelial markers (vWF, endothelin), and oxidative stress markers (MDA).
- Histopathological examination of lung biopsy specimens.
Main Results:
- The protective group demonstrated significantly better oxygenation (oxygen index, A-a O2 gradient) and reduced mechanical ventilation time and ICU stay.
- Lower levels of plasma malondialdehyde and tumor necrosis factor-alpha were observed in the protective group.
- Reduced levels of interleukin-6 and -8 in bronchoalveolar lavage fluid were noted in the protective group.
- Histopathology revealed less lung injury, including edema and leukocyte accumulation, in the protective group compared to the control group.
Conclusions:
- Pulmonary perfusion with hypothermic protective solution effectively mitigates lung injury associated with cardiopulmonary bypass in Tetralogy of Fallot repair.
- The protective mechanism likely involves the inhibition of lung vascular endothelial cell injury.
- This strategy offers a promising approach to improve outcomes in pediatric cardiac surgery patients.
Background:
The aim of this study was to evaluate the protective effect of pulmonary perfusion with hypothermic protective solution on lung function after cardiopulmonary bypass in corrections of Tetralogy of Fallot.
Methods:
Sixty-four consecutive children with Tetralogy of Fallot were randomly divided into a control group (n = 30) and a protective group (n = 34). Hypothermic protective solution was infused to the main pulmonary artery in the protective group. Hemodynamics and lung functions were monitored. Concentrations of malondialdehyde, tumor necrosis factor-alpha, von Willebrand factor, and endothelin in plasma were measured. The interleukin-6 and interleukin-8 levels in bronchoalveolar lavage fluid were also determined. Lung biopsy specimens were obtained after weaning from cardiopulmonary bypass.
Results:
Oxygenation values (oxygen index and alveolar-arterial O(2) gradient) were better preserved in the protective group than in the control group. The time of mechanical ventilation and length of intensive care unit stay were shorter in the protective group compared with the control group. The tumor necrosis factor-alpha and malondialdehyde levels in plasma increased in both groups after operations, and the rising extents were lower in the protective group than in the control group. The von Willebrand factor and endothelin levels in plasma increased more significantly in the control group than in the protective group. The concentrations of interleukin-6 and interleukin-8 in bronchoalveolar lavage fluid were lower in the protective group than in the control group. The examination of histopathology demonstrated capillary hyperemia and hemorrhage, intra-alveolar edema, leukocytes accumulation, mitochondria swelling and vacuolation, and gas-blood barrier broadening in the control group, whereas there were no significant changes in the protective group. The intercellular adhesion molecule-1 expression on lung vascular endothelial cells was stronger in the control group.
Conclusions:
Lung perfusion with hypothermic protective solution during cardiopulmonary bypass relieved lung injury in corrections of Tetralogy of Fallot. The inhibition of lung vascular endothelial cell injury may be the major mechanism of relieving cardiopulmonary bypass-induced lung injury.
More Related Videos
09:47Exploring Alternative Perfusion Solutions Using Next-Generation Polymerized Hemoglobin-Based Oxygen Carriers in a Model of Rat Ex Vivo Lung Perfusion
Published on: June 14, 2024
09:34Thermal Preconditioning During Ex-vivo Lung Perfusion for the Rehabilitation of Damaged Lung Grafts before Transplantation
Published on: October 31, 2025
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History: